Generic Name and Formulations:
Ferumoxsil 175mcg/mL; susp; contains parabens 1.4mg/mL.
Indications for GASTROMARK:
For oral use with magnetic resonance imaging to enhance the delineation of the bowel to distinguish it from organs and tissues that are adjacent to the upper regions of the GI tract.
Take after fasting at least 4 hours. 600mL orally at a rate of 300mL over 15 minutes. Max dose: 900mL. Optimal results occur within 30 minutes.
<16yrs: not recommended.
Known or suspected intestinal perforation or obstruction.
Current or recent hiatal hernia, esophageal reflux, nausea, vomiting, abdominal pain. Patients who cannot tolerate large fluid shifts and who are on specific fluid requirements. Inflammatory bowel disease. Disorders associated with iron overload (eg, hemosiderosis, chronic hemolytic anemia with frequent blood transfusions, chronic iron replacement). Avoid aspiration. Pregnancy (Cat.B). Nursing mothers.
Superparamagnetic iron oxide.
Diarrhea, flatulence, nausea, abdominal pain/cramps, dyspepsia, vomiting, oral paresthesia.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|